Diagnostic Modalities for VAP Detection

Study Overview
=================
Brief Summary
-----------------
asses diagnostic performance of different methods for detection of ventilator associated pneumonia.

Detailed Description
-----------------
Ventilator associated pneumonia (VAP) is a common cause of nosocomial infection, that can complicate mechanical ventilation and is related to significant utilization of health-care resources. The diagnosis of VAP is subjected to considerable interobserver variability. The Centers for Disease Control and Prevention (CDC) definition of VAP uses a combination of clinical, radiographic, and micro-biological criteria for diagnosis, but in the absence of a definite diagnostic test, the accurate diagnosis and treatment of VAP is limited. The clinical pulmonary infection score (CPIS) was developed to objectively diagnose VAP and assign points on the basis of clinical and radiographic data, but its role in diagnosing pneumonia remains controversial . Lung ultrasound (LUS) is a simple, non irradiating, noninvasive, cost-effective, bedside technique. It has been successfully applied for monitoring aeration and monitoring antibiotic efficacy in ventilator-associated pneumonia (VAP). However, no scientific evidence is yet available on whether LUS reliably improves the diagnosis of VAP. Quantitative bacterial cultures of the specimen obtained from the lower airways using bronchoscope were proposed for VAP diagnosis with a cut off value of 104 colony-forming unit/ml. However, microbiological cultures cannot guide the early clinical management of patients with a suspected VAP, as they need at least 24 hours for preliminary results. So, starting antibiotics remains a challenge. Moreover, bronchoscopy is not always easy to perform in hypoxemic patients and not promptly available in all ICUs. Therefore, it can be replaced by tracheal aspirate microbiological samples.

Official Title
-----------------
Assessment of Different Diagnostic Modalities for Detection of Ventilator Associated Pneumonia

Conditions
-----------------
Ventilator Associated Pneumonia

Intervention / Treatment
-----------------
* Diagnostic Test: bronchoalveolar lavage


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All adult patients mechanically ventilated for at least 48 hours in Respiratory ICU were included in the study. who had: Clinically suspected VAP according to simplified Clinical Pulmonary Infectious Score exceeding 6. Or new or extension of a radiological image with at least two of the following clinical criteria: Body temperature ≥ 38.5 ° C or <36 ° C. Leukocytes> 10 * 103 / ml or <4 * 103/ ml or > 10% immature cells (in the absence of other known causes). Purulent tracheal secretions. Hypoxemia with PaO2 <60 mmHg or a PaO2 / FiO2 <300. Exclusion Criteria: Patients with diagnosis of community acquired pneumonia or hospital acquired pneumonia before starting of mechanical ventilation. Patients who are contraindicated for bronchoscopy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Allocation: Non-Randomized
Intervention Model: Single Group Assignment


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: VAP group<br>patients confirmed diagnosis of VAP with bronchoalveolar lavage | Diagnostic Test: bronchoalveolar lavage<br>* endobronchial sampling through bronchoscopy<br>* Other names: protected endotracheal aspirate;|
| Experimental: Non VAP group<br>patients confirmed not VAP with bronchoalveolar lavage | Diagnostic Test: bronchoalveolar lavage<br>* endobronchial sampling through bronchoscopy<br>* Other names: protected endotracheal aspirate;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To detected diagnostic accuracy of chest ultrasound in VAP. | To identify sensitivity and specificity of chest ultrasound in VAP diagnosis | 3 years | 
| To detected diagnostic accuracy of protected endotracheal aspirate in VAP. | To identify sensitivity and specificity of protected endotracheal aspirate in VAP diagnosis | 3 years | 
| To detected diagnostic accuracy of usual endotracheal aspirate in VAP. | To identify sensitivity and specificity of usual endotracheal aspirate in VAP diagnosis | 3 years | 
| To detected diagnostic accuracy of chest X-ray in VAP. | To identify sensitivity and specificity of chest X-ray in VAP diagnosis | 3 years |